tranScrip is delighted to announce the appointment of Roz Sutton as Senior Director of Regulatory Affairs. Roz brings two decades of experience in Global Regulatory Affairs, having held leadership roles at top pharmaceutical companies including Roche and GSK, as well as in regulatory consultancy at DLRC. Her appointment underscores tranScrip’s commitment to strengthening its regulatory team as it continues to expand its expertise and service offerings.

We are delighted to announce that Dr. Kathryn (Kate) Owen has joined tranScrip as Executive Medical Director in our Early Development Group.

Kate brings with her 24 years of extensive experience as a consultant Pharmaceutical Physician, with a specialised focus in oncology and haemato-oncology. She has an exceptional track record in early clinical development, guiding projects from candidate drug selection through to phase IIb trials.

Cambridge, UK – 16 October 2024 – The Cambridge Crystallographic Data Centre (CCDC) announces two significant scientific papers detailing the findings of the 7th Crystal Structure Prediction (CSP) Blind Test. To coincide with the publication of the two papers, the CCDC has released a CSP Blind Test database that contains 171,679 entries from 207 landscapes.

Expanding CSP Beyond Pharmaceuticals

Glucose sensing and continuous glucose monitoring (CGM) manufacturer for diabetes management, Dexcom, and pharmaceutical and medical devices organisation, Abbott, have been locked in a series of patent disputes over their continuous glucose monitoring (CGM) devices and systems, in a battle that spans multiple patents and several jurisdictions including the UK, US and Germany. In the UK alone, both parties have brough infringement proceedings, with a total of seventeen patents being at issue.

In January 2024 Cameroon launched the world’s first routine malaria vaccine programme. By incorporating the RTS,S vaccine into its standard immunisation schedule, Cameroon aims to protect thousands of children across Africa and significantly reduce malaria-related fatalities.

Closely following suit, the Côte d’Ivoire has recently become the first country to roll-out the new R21/Matrix-M™ vaccine, in another key advancement in the battle against malaria.

• Series C round led by Elevage Medical Technologies
• Funding will accelerate the commercialization of Nuclera’s eProtein Discovery platform, to optimize protein expression and purification workflows within research labs globally